Endocrine · Endocrine research peptide · GHRF-010
GTP-Binding Protein Fragment, G alpha
- Drug class
- Endocrine research peptide
- Status
- Research use only
- Catalog code
- GHRF-010
- Also known as
- GHRF-010
- Reviewed
- 2026-06-01 · Kindr Health Clinical Team
What GTP-Binding Protein Fragment, G alpha is studied for
- Receptor-binding and functional selectivity studies
- Second-messenger (cAMP / IP₁) profiling
- Hypothalamic–pituitary axis feedback modeling
- Metabolic and glucose-homeostasis research
Mechanism of action
GTP-Binding Protein Fragment, G alpha sits within the Endocrine research class (CPC reference GHRF-010). Endocrine peptides bind class A/B GPCRs and RTKs on hormone-responsive tissues, triggering canonical cAMP, IP₃/Ca²⁺, and MAPK pathways that regulate secretion, growth, and metabolism. Investigators typically incorporate GTP-Binding Protein Fragment, G alpha as a reference standard, tool ligand, or substrate in the assay contexts listed above. HTRF cAMP, calcium mobilization (FLIPR), and radioligand binding are the standard readouts.
Frequently asked questions
What is GTP-Binding Protein Fragment, G alpha?
GTP-Binding Protein Fragment, G alpha (CPC catalog code GHRF-010) is a synthetic endocrine research peptide in the endocrine category. It is provided as a lyophilized ~1 mg vial for in-vitro research use only.
What is GTP-Binding Protein Fragment, G alpha studied for?
Published and internal research programs use GTP-Binding Protein Fragment, G alpha as a reference standard in endocrine workflows — for example, receptor-binding and functional selectivity studies and second-messenger (camp / ip₁) profiling. Human clinical evidence is not established.
Is GTP-Binding Protein Fragment, G alpha FDA-approved for human use?
No. GTP-Binding Protein Fragment, G alpha is a research-grade reference peptide and is not approved by the FDA or any national regulator for human or veterinary therapeutic use. It is offered exclusively for in-vitro laboratory research and does not ship to the United States for consumer use.
How is GTP-Binding Protein Fragment, G alpha typically used in the lab?
In a endocrine workflow, GTP-Binding Protein Fragment, G alpha is reconstituted in sterile buffer or DMSO (solubility-dependent) and applied in the researcher's chosen assay format. HTRF cAMP, calcium mobilization (FLIPR), and radioligand binding are the standard readouts.
How should GTP-Binding Protein Fragment, G alpha be stored?
Store lyophilized at −20 °C, protected from light. Reconstitute in sterile 0.1% BSA/PBS. Follow your institution's standard operating procedures for handling synthetic peptides.
Where does the GTP-Binding Protein Fragment, G alpha product page point to?
This kindr reference page mirrors CPC Scientific's catalog metadata for GHRF-010. The upstream reference sheet — including sequence, purity, MW, and application notes where published — is linked from the buy panel. All orders placed on kindr Peptides ship internationally under research-use terms only.
What quality specifications apply to GTP-Binding Protein Fragment, G alpha?
Research-grade peptides in the CPC catalog are synthesized by solid-phase peptide synthesis (SPPS), purified by preparative RP-HPLC, and characterized by analytical HPLC and mass spectrometry. Typical purity is ≥95%; certificate of analysis is available on request.
Related peptides in Endocrine
Continue across the Kindr entity graph
Related evidence, peptides, and clinical tools on the same topic.
- Is HRT safe?Journal
- When to start HRTJournal
- Menopause HRT serviceMedication
- Complete menopause guideJournal